Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.4100 (1.51%) ($11.4100 - $11.4100) on Mon. Apr. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.01% (three month average) | RSI | 71 | Latest Price | $11.4100(1.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.505% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-2%) IGOV(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.505% (StdDev 7.01%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.77(5.94%) | 10 Day Moving Average | $10.47(8.98%) | 20 Day Moving Average | $10.43(9.4%) | To recent high | -16.3% | To recent low | 32.7% | Market Cap | $2.013b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |